Summit Therapeutics plc Gains 38.65%
Tue, Dec 13, 2022 at 07:09 PM
Summit Therapeutics plc (SMMT:NASDAQ) rocketted at $3.91, representing a gain of 38.7%. On Tue, Dec 13, 2022, SMMT:NASDAQ touched a New 2-Week Intraday High of $4.15. The stock got featured on our News Catalysts scanner on Fri, Dec 09, 2022 at 10:05 AM in the 'INSIDER' category. From Tue, Nov 29, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Thu, Dec 08, 2022 at $4.5 with a volume of 89M+.
About Summit Therapeutics plc (SMMT:NASDAQ)
Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.
Top 10 Gainers:
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- OpGen, Inc. (OPGN:NASDAQ), 84.8%
- Vincerx Pharma Inc. (VINC:NASDAQ), 58.82%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 52.78%
- Shineco Inc. (SISI:NASDAQ), 49.23%
- Puhui Wealth Investment Management Co., Ltd. (PHCF:NASDAQ), 43.8%
- Summit Therapeutics plc (SMMT:NASDAQ), 38.65%
- BeyondSpring Inc. (BYSI:NASDAQ), 35.94%
- Kaspien Holdings Inc. (KSPN:NASDAQ), 33.83%
- Wave Life Sciences Ltd. (WVE:NASDAQ), 32.69%